Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

返回 Agenda

Topic 2 Session 8: MedDRA and Standardised MedDRA Queries (SMQs)

Speaker(s)

MedDRA and Standardised MedDRA Queries (SMQs)

Sarah Vaughan

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Head of Vigilance Operations

Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

Topic 2 Session 8: MedDRA and Standardised MedDRA Queries (SMQs)

Speaker(s)

MedDRA and Standardised MedDRA Queries (SMQs)

获得信息并保持参与